Fed- and Fasted-State Performance of Pretomanid Amorphous Solid Dispersions Formulated with an Enteric Polymer-Reference-Cited by-同舟云学术

Fed- and Fasted-State Performance of Pretomanid Amorphous Solid Dispersions Formulated with an Enteric Polymer

Published:2023-05-23 Issue:6 Volume:20 Page:3170-3186
ISSN:1543-8384
Container-title:Molecular Pharmaceutics
language:en
Short-container-title:Mol. Pharmaceutics

Author:

Nguyen Hanh Thuy¹,Van Duong Tu¹^ORCID,Jaw-Tsai Sarah²,Bruning-Barry Rebecca³,Pande Poonam⁴,Taneja Rajneesh⁴,Taylor Lynne S.¹^ORCID

Affiliation:

1. Department of Industrial and Physical Pharmacy, College of Pharmacy, Purdue University, West Lafayette, Indiana 47907, United States

2. Sarah Jaw-Tsai Consulting Services, 12279 Skyracer Drive, Las Vegas, Nevada 89138, United States

3. Global Health Technologies Program, RTI International, Research Triangle Park, North Carolina 27704, United States

4. Global Alliance for TB Drug Development (TB Alliance), 80 Pine Street, 20th Floor, New York, New York 10005, United States

Funder

Bill and Melinda Gates Foundation

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Pharmaceutical Science,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.molpharmaceut.3c00174

Reference69 articles.

1. Pretomanid: First Approval

2. Highlights of Prescribing Information: Pretomanid Tablets, for Oral Use; Application Number 212862 Orig1s000; FDA Center for drug evaluation and research, 2019. https://www.accessdata.fda.gov/drugsatfda_docs/nda/2019/212862Orig1s000MultidisciplineR.pdf.

3. Highlights of Prescribing Information: Pretomanid Tablets, for Oral Use; Application Number: 212862s004; FDA Center for Drug Evaluation and Research, 2022. https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/212862s004lbl.pdf.

4. Rapid Communication: Key Changes to the Treatment of Drug-Resistant Tuberculosis; World Health Organization, 2022.

5. Synthesis and Structure−activity Relationships of Antitubercular 2-Nitroimidazooxazines Bearing Heterocyclic Side Chains

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prediction of pharmacokinetics of an anaplastic lymphoma kinase inhibitor in rat and monkey: application of physiologically based pharmacokinetic model as an alternative tool to minimise animal studies;Xenobiotica;2023-12-02

2. Amorphous solid dispersions: Stability mechanism, design strategy and key production technique of hot melt extrusion;International Journal of Pharmaceutics;2023-11

3. HPMCAS-Based Amorphous Solid Dispersions in Clinic: A Review on Manufacturing Techniques (Hot Melt Extrusion and Spray Drying), Marketed Products and Patents;Materials;2023-10-10

4. Crystallinity: A Complex Critical Quality Attribute of Amorphous Solid Dispersions;Molecular Pharmaceutics;2023-09-12

5. Enteric coating of tablets containing an amorphous solid dispersion of an enteric polymer and a weakly basic drug: A strategy to enhance in vitro release;International Journal of Pharmaceutics;2023-07